Impact of Tobacco Smoking on Lipid Metabolism, Body Weight and Cardiometabolic Risk

Author(s): Amalia Gastaldelli, Franco Folli, Silvia Maffei

Journal Name: Current Pharmaceutical Design

Volume 16 , Issue 23 , 2010

Become EABM
Become Reviewer
Call for Editor


Tobacco smoking is the most important preventable cause of cardiovascular disease. In this paper we review current epidemiological and pathophysiological evidence linking smoking with cardiovascular and metabolic diseases. Among the effects of smoking there is the alteration of lipid metabolism through the increase in lipolysis, insulin resistance and tissue lipotoxicity. Smoking is both prothrombotic and atherogenic. As an effect, the risk of acute myocardial infarction, sudden cardiac death, stroke, aortic aneurysm and peripheral vascular disease is increased. Even very low doses of exposure increase the risk of cardiovascular disease (CVD) and metabolic alterations. On the other hand, smoking cessation restores, at least in part, lipid metabolism and the benefits can be observed already after a short period of abstinence from smoking, although it occurs several years before the risks approach those of the never-smoker.

Keywords: Insulin resistance, lipolysi, tobacco smoking, nicotine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [2526 - 2530]
Pages: 5
DOI: 10.2174/138161210792062858
Price: $65

Article Metrics

PDF: 23